NCT06190730 REmote Symptom COllection to improVE postopeRative Care
| NCT ID | NCT06190730 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medstar Health Research Institute |
| Condition | Gastrointestinal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 281 participants |
| Start Date | 2024-07-23 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 281 participants in total. It began in 2024-07-23 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.
Eligibility Criteria
Inclusion criteria 1. At least 18 years old. Ages of subjects \>89 will simply be reported as \>90. 2. Scheduled for a GI surgery for management of a tumor in a participating hospital. 3. Fluent in oral and written English. 4. Has consistent and continued full access to an operational Wi-Fi for the duration of the study. Exclusion criteria 1. Unable to provide informed consent. 2. Not willing to commit to regular participation in the study to include daily use (40 days) of the study application. 3. Life expectancy of less than 60 days. 4. In the opinion of the investigator, participation in this study is contraindicated.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06190730 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastrointestinal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06190730 currently recruiting?
Yes, NCT06190730 is actively recruiting participants. Contact the research team at nawar.shara@medstar.net for enrollment information.
Where is the NCT06190730 trial being conducted?
This trial is being conducted at Baltimore, United States, Omaha, United States.
Who is sponsoring the NCT06190730 clinical trial?
NCT06190730 is sponsored by Medstar Health Research Institute. The trial plans to enroll 281 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.